“Bringing the world into focus
through the lens of Scripture”

 

 

 

 

frosty@khouseafrica.com

 

 

 

K-House Africa

 

Banking Details

 

 

 Africa news

 

THE STRUGGLE FOR JERUSALEM

 

 

The Rise Of Islam

 

 

THE DECLINE OF THE USA

 

 

GLOBAL RELIGION

 

 

GLOBAL PESTILENCE

 

 

Global Government

 

 

THE RISE OF THE FAR EAST

 

 

THE RISE OF THE EUROPEAN SUPER STATE

 

 

WEAPONS PROLIFERATION

 

 

THE MAGOG INVASION

 

 

 

 Kings High Way Briefing Packs

 

 

 

 

INTERNATIONAL NEWS FEEDS


 

 In The News provided by Koinonia House

Monitor The Strategic Trends

Biotech & Global Pestilence Introduction:

 

The threat of germ warfare has brought to the forefront long-forgotten diseases like plague, anthrax, and smallpox. Recent television news programs have highlighted secret projects in the former Soviet Union to develop antibiotic-resistant strains of genetically engineered viruses and bacteria.


[READ THE FULL INTRODUCTION]

 

 


 
 

Human Nature

Speakers:

Ron Matsen

R179.00

 

 

 

About available formats

Description: 

What does it mean to be human? Philosophers, theologians, sociologists and psychologists have attempted to understand the nature of mankind for ages. Their conclusions often contradict each other which lead to confusion rather than clarification. Clearly Man is a very complicated social being. The Bible tells us that man is “fearfully and wonderfully made.”
  • How do we understand our makeup and does it make a difference?
  • What is the meaning of being “created in the image of God?”
  • What causes our natural responses and can we change this behaviour?

Join Ron Matsen from the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of our “Human Nature” and gives insight into the architecture and accountability of all mankind.

This briefing pack contains approx. 2 hours of teaching.

  • DVD discs
  • M4A files
  • PDF Notes file
  •  

 

 

 

 

 
 

 

CANCER  Awareness

 

 

 

http://news.yahoo.com/rss/cancer

 

Our Precious Daughter Penny

Penny has been the bravest and shining example the Lord could have chosen and will be a witness to the Glory of God and the faithfulness of His promises forever.

We give thanks to all who supported her with their prayers, may God pour out His everlasting Love over you forever.
BARBARA & RICHARD FROST & FAMILY
 

 

 

 

 

 

We are humbled beyond words by the Glory of God's Grace.

We will be forever grateful for the the wonderful friends praying continuously for Penny and her family.

 

 

Biotech & Global Pestilence

 

Cancer News Headlines

 

Hallmarks of Cancer 1: Self-Sufficiency in Growth Signals

 

Linda Ronstadt - Desperado (Simple Dreams Tour ... - YouTube

► 3:46► 

www.youtube.com/watch?v=oAK5Ids7l5g
With roots in the Los Angeles country and folk-rock scenes, Linda Ronstadt became one of the most popular ...

 

Linda Ronstadt & James Ingram - "Somewhere Out There"

 

 

Linda Ronstadt - Tracks Of My Tears

 

 

 

Linda Ronstadt - Long Long Time Linda Ronstadt

 

 

 

Treasury Comments..

 

PENNY

 

 

 

 

 

Price R 179

 

 

 

 

Beginning of Wisdom

 

by

 Dr. Chuck Missler

“The fear of God is the beginning of wisdom.” Proverbs 9:10

But how do we balance the awesome majesty due to the Creator and Ruler of the universe with the gracious family intimacy that is now available to us through the completed work of Christ?

What does His Holiness demand of us, personally?

What are the hazards of failing to render the Almighty His due, while availing ourselves the riches committed to us of the precious promises in His Word?

How do we deal with these paramount issues facing us daily in practical challenges?

Chuck Missler grapples with these wildly misunderstood tensions with down-to-earth frankness and Biblically-based candor.

 


 

 

Price R 179.00

 

 

The Gospel: The Message of Reconciliation

DVD

by Ron Matsen 

 

 

 

Price R 179.00

 

 

 

Description

One of the last instructions given by Jesus to the Church was, “Go into all the world and preach the gospel.” (Mark 16:15)

The fact is most Christians don’t know how to share their faith effectively. Sadly, many of the people they know in the world today are wandering around, lost and without hope, having never heard the wonderful Message of Reconciliation.

How would you answer the question, “What must I do to be saved?”

What are the essential facts, demands and promises of the Gospel?

Why are we told to evangelize?

Join Ron Matsen in the Executive Briefing Room of the River Lodge, New Zealand as he explores the subject of “The Gospel – The Message of Reconciliation” and gives practical insight into how to share the essential doctrines of salvation.

This briefing pack contains 2 hours of teaching

© Copyright 2013

 

 

 

Disaster Management News from TerraDaily.com

 

Earth News, Earth Science, Energy Technology, Environment News

 

 

 

NEW DEDICATED PAGE

 

SABC NewsSABC Logo

 

I WILL CURSE THOSE WHO

 

 CURSE THEE'

 

 

THE PERFECT STORM

 

Price R599.00

 

 

 

 

·         Dr. Chuck Missler - The seven Myths of Eschatology, How to Avoid Deception, Know Your Calling.

·         Dr. Steve Elwart - What is the World Coming To? A Global Intelligence Update. 

·         Chris Corlett - On Education: Playgrounds, Politics and Parents.

·         Gary Stearman - New Insights on the Last Generation, Abraham and the Four Kings.

·         Joel Richardson - The Rise of Antichrist, Encouragement for the Last Days.

·         Dr. William Welty - The Validity of the State of Israel.

·         Chris Putnam - Astrobiology: The 'Science' With Nothing To Study, Who are the Immortals Driving Paranormal Paradigm Shift?

·         David McAlvany - A Legacy of Debt, International Families: Your Family Legacy From Finish to Start. 

·         Bob Cornuke - Traditions,Temples and Beyond, Alternate Location of the Crucifixion.

·         Joseph Farah - Restoration vs. the Spirit of Diotrephes.

·         Ron Matsen - Finding Peace in the Face of Peril. 

·         Lt. Col. Robert Maginnis, US Army (retired) - Never Submit.

 

 

 

 

Behold a Livid Horse: Emergent Diseases and Biochemical Warfare

 

 

PRICE R 249.00

 

 

 

Behold a Livid Horse:

 Emergent Diseases

 and

Biochemical Warfare

 

DVD

 

by Dr. Chuck Missler

 

 

Dr. Chuck Missler explores these and other questions below concerning this climactic Fourth Horsemen and the unique role it plays in the End-Time Scenario:

•Why are previously conquered diseases now making a comeback?

•How real is the threat of biological terrorism?

•Why is it more dangerous than chemical terrorism?

•Was the AIDS virus deliberately designed? By whom? And why?

•Is there any truth behind an agenda to control (and reduce) the world’s population? By whom? And why?

•Who are the two riders associated with the Livid Horse? How do they differ?

 

This briefing pack contains 2 hours of teaching

 

Available in the following formats

 

DVD:

•2 MP3 files

•1 PDF Notes file

•Colour, Full screen 16:9, Dolby Digital 2.0 stereo,

 

 

Diseases/Conditions News Headlines - Yahoo! News

 

 
 

Researchers successfully block colon cancer tumor growth

 
‎Yesterday, ‎July ‎22, ‎2016, ‏‎5:57:40 PMGo to full article
Over one million men and women are living with colorectal cancer in the USA.Researchers in the USA have discovered that reducing the amount of the L-glutamine amino acid in the body can block the growth of colorectal cancer tumors in mice. The first clinical trials on humans are due to begin this summer. Recent research has established that cancerous tumors rely on L-glutamine to survive and grow. In this latest study, scientists found that a subset of colorectal cancer cells containing a genetic mutation called PIK3CA -- a commonly occurring mutation in cancer cells -- were particularly high consumers of L-glutamine when growing.
 
 

Scientists hunt 'anti-evolution' drugs in new cancer fight

 
‎Yesterday, ‎July ‎22, ‎2016, ‏‎1:03:19 AMGo to full article
Scientist prepares protein samples for analysis in a lab at the Institute of Cancer Research in SuttonBy Ben Hirschler LONDON (Reuters) - Scientists are opening a new front in the war on cancer with plans to develop "anti-evolution" drugs to stop tumor cells from developing resistance to treatment. Britain's Institute of Cancer Research (ICR), one of the world's top cancer centers, said on Friday its initiative was the first to have at its heart the target of overcoming cancer evolution and drug resistance. In the same way that bacteria evolve resistance to antibiotics, cancer cells also change to evade the medicines used to fight them, leading to "survival of the nastiest".
 
 

Pre-stroke lifestyle tied to long term risk of more strokes, dementia

 
‎Thursday, ‎July ‎21, ‎2016, ‏‎6:10:38 PMGo to full article
By Kathryn Doyle (Reuters Health) - Having heart disease risk factors like high blood pressure before suffering a stroke may influence a person’s risk for a second stroke or dementia years later, according to a new study from the Netherlands. In recent years, medication advances have helped cut health risks in the year following a stroke, but after that the risk of a second stroke or dementia remains elevated for at least five years, said senior author Dr. M. Arfan Ikram from Erasmus University Medical Center in Rotterdam. “As more stroke patients survive in the short term, automatically more patients survive into the long term,” Ikram told Reuters Health.
 

Amgen, Allergan biosimilar found as effective as Roche cancer drug

 
‎Thursday, ‎July ‎21, ‎2016, ‏‎4:31:44 PMGo to full article
File photo of an Amgen sign at the company's office in South San Francisco(Reuters) - Amgen Inc and Allergan Plc said their copycat version of Roche Holding AG's blockbuster cancer treatment, Herceptin, was found as effective as the original in a late-stage study. There were no "clinically meaningful" differences in data gathered from patients given Herceptin and the copycat version, ABP 980, to treat a type of early breast cancer, said Sean Harper, Amgen's executive vice president of research and development.
 
 

New technique opens window into how brain cells communicate

 
‎Wednesday, ‎July ‎20, ‎2016, ‏‎9:37:13 PMGo to full article
In this photo provided by Science Translational Medicine, PET scans taken at the Yale PET Center show the density of connections between nerve cells, called synapses, in a healthy living brain. Yale researchers developed a way to picture synapses in a living brain, something that until now has been studied mostly during autopsies. (Science Translational Medicine via AP)WASHINGTON (AP) — The brain's nerve cells communicate by firing messages to each other through junctions called synapses, and problems with those connections are linked to disorders like Alzheimer's and epilepsy. Now Yale University researchers have developed a way to picture synapses in living brains.
 
 

Mind over gray matter: new map lays out brain's cerebral cortex

 
‎Wednesday, ‎July ‎20, ‎2016, ‏‎7:04:45 PMGo to full article
A 180-area multimodal human cortical parcellation on the left and right hemisphere surfaces of the human brain is pictured in this handout imagegeBy Will Dunham WASHINGTON (Reuters) - Neuroscientists acting as cartographers of the human mind have devised the most comprehensive map ever made of the cerebral cortex, the part of the brain responsible for higher cognitive functions such as abstract thought, language and memory. Using MRI images from the brains of 210 people, the researchers said on Wednesday they were able to pinpoint 180 distinct areas in the cerebral cortex, the brain's thin, wrinkly outermost layer made of so-called gray matter. The map could assist in the study of brain maladies such as autism, schizophrenia, dementia and epilepsy, and shed light on the differences between the brains of people with such conditions and healthy people, the researchers said.
 
 

Only extreme sitting linked to increased heart disease risk

 
‎Wednesday, ‎July ‎20, ‎2016, ‏‎5:04:38 PMGo to full article
By Kathryn Doyle (Reuters Health) – Being sedentary, at least in moderation, is unlikely to cause heart disease, according to a new review of past research. Based on their analysis, researchers conclude that only very high levels of sedentary time - more than 10 hours per day - are linked to an increased risk of heart attack, stroke or heart disease-related death. Compared to sitting for less than three of one’s waking hours each day, more than 10 hours of sedentary time was tied to an 8 percent increase in risk for developing heart disease.
 

Eating oily fish may boost bowel cancer survival: study

 
‎Wednesday, ‎July ‎20, ‎2016, ‏‎10:25:26 AMGo to full article
Eating oily fish may boost bowel cancer survival: studyPeople with bowel cancer may improve their survival chances by eating a lot of omega 3 fatty acids found in oily fish like tuna and salmon, a study suggested Wednesday. Analysis of data from more than 170,000 people in the United States revealed that among 1,659 who developed bowel cancer, there was a strong correlation between higher omega 3 intake and lower risk of death, it said. "Compared with patients who consumed less than 0.1 grammes (0.004 ounces) of omega 3 fatty acids daily, those who consumed at least 0.3 grammes daily after their diagnosis, had a 41 percent lower risk of dying from their disease," said a statement on the findings published in the British journal Gut.
 
 

Hunger, looting and now suspected cholera hit South Sudan

 
‎Tuesday, ‎July ‎19, ‎2016, ‏‎7:40:45 PMGo to full article
A worker from the International Committee of the Red Cross (ICRC) prepares to move bags containing bodies of unidentified people killed in the recent fighting in checkpoint area of JubaBy Tom Miles GENEVA (Reuters) - Dozens of people have fallen ill with suspected cholera in South Sudan's capital of Juba, while a U.N. food warehouse was looted and destroyed, incurring $20 million of damage, the United Nations said on Tuesday. "We expect a huge humanitarian crisis. Cholera is a type of acute watery diarrhea which kills fewer than 1 percent of sufferers if there is proper treatment with oral rehydration salts, according to the World Health Organisation.
 
 

Celgene to collaborate with tiny Jounce on cancer immunotherapy

 
‎Tuesday, ‎July ‎19, ‎2016, ‏‎1:25:25 PMGo to full article
Privately held Jounce Therapeutics Inc, which is working on treatments designed to use a patients' own immune systems to better attack cancer, said on Tuesday it had entered into an collaboration and investment agreement with Celgene Corp worth more than $2.5 billion. The deal for the tiny Cambridge, Massachusetts-based company comes just at little more than three years after it was launched with funding from life sciences investor Third Rock Ventures. Bristol-Myers Squibb Co and Merck Inc are currently considered the leaders in the immunotherapy race, which has produced drugs that have resulted in unprecedented survival rates for some of the most deadly diseases, including advanced melanoma and advanced lung cancer.
 

11 dead in suspected South Sudan cholera outbreak: UNICEF

 
‎Tuesday, ‎July ‎19, ‎2016, ‏‎12:58:24 PMGo to full article
FILE--- In this Saturday May 24, 2014 file photo a South-Sudanese family waits in the cholera isolation ward of Juba Teaching Hospital in the capital Juba, South Sudan. UNICEF says 11 people have died in a suspected cholera outbreak in South Sudan. The organization said Tuesday there are 72 suspected cases so far, including 36 in the capital, Juba. Others are in Bor and Terekeka counties.(AP Photo/Matthew Abbott/file)JUBA, South Sudan (AP) — UNICEF says 11 people have died in a suspected cholera outbreak in South Sudan.
 
 

Old pharma sees new profit cure in cancer drugs

 
‎Tuesday, ‎July ‎19, ‎2016, ‏‎7:08:18 AMGo to full article
A person holds pharmaceutical tablets and capsules in illustration picture in LjubljanaBy Carl O'Donnell (Reuters) - Some of the world's largest drug companies are taking out their checkbooks for acquisitions of smaller peers whose cancer drugs have the potential to cure not just patients, but corporate growth prospects as well. After decades in which progress meant extending life by weeks or months, new cancer treatments hold promise of adding years to patients' lives and billions of dollars in revenue to the companies that own them. Some of the most promising, known as immunotherapy, harness the body's own defense system to fight cancer.
 
 

Fracking associated with asthma flare-ups

 
‎Tuesday, ‎July ‎19, ‎2016, ‏‎3:08:45 AMGo to full article
By Lisa Rapaport (Reuters Health) - For asthma patients, living near fracking sites is associated with more symptom flare-ups that require medication and hospital care, a U.S. study suggests. Air pollution has long been known to worsen asthma. “Residents of communities undergoing (fracking) and those nearby can be exposed to noise, light, vibration, heavy truck traffic, air pollution, social disruption and anxiety,” Sara Rasmussen of Johns Hopkins University in Baltimore told Reuters Health by email.
 

Fracking may worsen asthma for nearby residents, study says

 
‎Monday, ‎July ‎18, ‎2016, ‏‎10:07:55 PMGo to full article
FILE - In this June 9, 2014 file photo, drivers and their tanker trucks, capable of hauling water and hydraulic fracturing liquid, line up near a natural gas burn off flame and storage tanks in Williston, N.D. According to a 2005-12 study at Geisinger Clinic in Pennsylvania, fracking may worsen asthma in children and adults who live near natural gas drilling sites. People with asthma are vulnerable to air pollution, and diesel exhaust from heavy truck traffic involved in the process may be one of the culprits, although the study doesn't prove what caused patients' symptoms. (AP Photo/Charles Rex Arbogast)CHICAGO (AP) — Fracking may worsen asthma in children and adults who live near sites where the oil and gas drilling method is used, according to an 8-year study in Pennsylvania.
 
 

Asthma risk up to 4x higher near fracking sites: US study

 
‎Monday, ‎July ‎18, ‎2016, ‏‎9:50:10 PMGo to full article
Asthma risk up to 4x higher near fracking sites: US studyLiving near sites that extract natural gas by hydraulic fracturing, also known as fracking, may increase the risk of asthma up to four times, a US study said Monday. The findings, published in the Journal of the American Medical Association (JAMA) Internal Medicine, are based on research examining health records collected from 2005 to 2012 in the northeastern state of Pennsylvania. The researchers found more than 35,000 asthma patients aged from five to 90.
 
 

China approves use of GSK vaccine Cervarix for cervical cancer

 
‎Monday, ‎July ‎18, ‎2016, ‏‎10:37:58 AMGo to full article
File photo of the GlaxoSmithKline building in Hounslow, west LondonDrugmaker GlaxoSmithKline Plc said on Monday the China Food and Drug Administration (CFDA) has approved its human papillomavirus (HPV) vaccine, Cervarix, for use in the country to help women fight cervical cancer. GSK's China unit said in a statement Cervarix will be the first HPV vaccine licensed for use in the country and is expected to be launched there in early 2017. Cervical cancer is the second most common cancer in women aged between 15 to 44 years in China, with an estimated 130,000 new cases each year, it said.
 
 

AstraZeneca's lung cancer drug meets main goal in late-stage trial

 
‎Monday, ‎July ‎18, ‎2016, ‏‎8:52:51 AMGo to full article
The logo of AstraZeneca is seen on medication packages in a pharmacy in London(Reuters) - AstraZeneca Plc said its experimental lung cancer drug Tagrisso met its main goal in a late-stage study. The tablet, which has won early approval from both U.S. and European regulators, is one of several cancer medicines AstraZeneca hopes will rebuild its sales following patent losses on older drugs. AstraZeneca said Tagrisso showed superior progression-free survival compared to standard platinum-based chemotherapy. The trial assessed Tagrisso's efficacy and safety as a second-line treatment for certain kinds of lung cancer, the drugmaker said. ...
 
 

Roche receives blood cancer drug blow after Gazyva trial fails to meet endpoint

 
‎Monday, ‎July ‎18, ‎2016, ‏‎8:33:09 AMGo to full article
Swiss drugmaker Roche's logo is seen at their headquarters in BaselSwiss drugmaker Roche said trials showed its new blood cancer drug Gazyva failed to deliver significant improvements over an older medicine in people with an aggressive type of blood cancer, a blow in its fight against competition from biosimilars. Gazyva did not significantly reduce the risk of disease worsening or death for people with previously untreated diffuse large B-cell lymphoma, over current drug Rituxan in a phase III GOYA study, Roche said on Monday. Diffuse large B-cell lymphoma is the most common form of non-Hodgkin's lymphoma.
 
 

Biden announces 'unprecedented' US-Australia cancer database

 
‎Sunday, ‎July ‎17, ‎2016, ‏‎7:48:26 AMGo to full article
US Vice President Joe Biden (C) speaks to guests after a tour of the Victorian Comprehensive Cancer Centre in Melbourne, on July 17, 2016US Vice President Joe Biden on Sunday unveiled a series of agreements between the US and Australia to create an "unprecedented" international research database of cancer patients as he kicked off a three-day visit in Melbourne. Fighting cancer is a personal goal for Biden, who lost his son Beau Biden to brain cancer last year, with the opening of an Aus$1 billion (US$760,000) medical facility his first event on his Australia tour, ahead of talks with Australian Prime Minister Malcolm Turnbull.
 
 

More evidence poor sleep habits may raise diabetes risk

 
‎Friday, ‎July ‎15, ‎2016, ‏‎8:03:02 PMGo to full article
By Lisa Rapaport (Reuters Health) - Men who don’t get the right amount of sleep may have an increased risk of developing diabetes, a recent study suggests. Plenty of previous research has linked sleep problems to diabetes, but the reasons behind this connection still aren’t well understood, said lead study author Femke Rutters of Vrije University Medical Center in Amsterdam. Researchers examined data on sleep patterns and insulin resistance for 788 men and women who didn’t have diabetes.
 

Bird flu outbreak in west Africa raises worries about food and livelihoods

 
‎Friday, ‎July ‎15, ‎2016, ‏‎6:42:35 PMGo to full article
By Magdalena Mis ROME (Thomson Reuters Foundation) - The outbreak of a highly contagious strain of avian flu in west and central Africa has stoked fears that the disease may become endemic in the region, with lasting implications for people's livelihoods, the U.N. food agency said on Friday. H5N1 avian influenza, or bird flu, has spread across a number of West African countries in the past two years, hitting poultry farms. Cameroon and Niger have become the latest countries affected in the region, in an outbreak that has hit Burkina Faso, Ivory Coast, Ghana and Nigeria.
 

Cancer patient dies after Ziopharm experimental drug therapy

 
‎Friday, ‎July ‎15, ‎2016, ‏‎4:46:07 PMGo to full article
(Reuters) - Ziopharm Oncology Inc said a brain cancer patient died of cranial bleeding about two weeks after starting treatment with the gene therapy developer's lead experimental drug, sending its stock down as much as 16 percent on Friday. The death of the patient with a recurrent brain tumor was announced in a single bullet point in a series of slides as part of a filing with the U.S. Securities and Exchange Commission on Thursday. Ziopharm also reported two other deaths of patients in trial but said they were unrelated to the drug.
 

Estrogen patch may cut Alzheimer's risk for newly postmenopausal women

 
‎Friday, ‎July ‎15, ‎2016, ‏‎1:11:20 PMGo to full article
Estrogen patches were found to reduce the levels of beta-amyloid deposits typically found in the brains of people with Alzheimer’s disease.Estrogen patches, used as hormone therapy for newly postmenopausal women, could cut the risk of Alzheimer's disease, according to an American study published in the Journal of Alzheimer's Disease. This new study could influence the decision of menopausal women when choosing a type of hormone therapy. The hormone can be administered to menopausal women by means of a patch.
 
 

UK charity pockets $150 million from Merck cancer immunotherapy drug

 
‎Friday, ‎July ‎15, ‎2016, ‏‎1:24:14 AMGo to full article
British medical charity MRC Technology has pocketed $150 million by selling part of its royalty interest in Merck & Co's successful cancer drug Keytruda, allowing it to plough fresh funds into new research. The charity said on Friday that a private equity fund managed by DRI Capital had acquired a portion of its royalty entitlement on the worldwide sales of the medicine. Keytruda is one of a promising class of new treatments that stimulate the body’s immune system to fight cancer.
 

Why Mental Health Is A Top Priority For The U.S. Surgeon General

 
‎Thursday, ‎July ‎14, ‎2016, ‏‎9:55:14 PMGo to full article
Why Mental Health Is A Top Priority For The U.S. Surgeon GeneralAs the U.S. Surgeon General, it’s Vivek Murthy’s responsibility to provide Americans with the best information for maximizing their heath in every way. That’s exactly why Murthy has made emotional well-being a priority during his tenure.In a recent conversation with HuffPost editor-in-chief Arianna Huffington, Murthy explained how...
 
 

Detained 'Boko Haram supporters' dying of torture, disease in Cameroon: Amnesty

 
‎Thursday, ‎July ‎14, ‎2016, ‏‎10:08:14 AMGo to full article
By Kieran Guilbert DAKAR (Thomson Reuters Foundation) - More than 1,000 people accused of supporting Boko Haram in Cameroon are being detained in military bases and prisons, often without any evidence, and dozens are dying from disease, malnutrition and torture, a rights group said on Thursday. Since a regional offensive last year drove Boko Haram from most of their strongholds, the Islamist militants have waged a guerrilla-style campaign targeting civilians. In Cameroon, teenage girls have killed dozens in suicide bombings carried out by the group.
 

Antipsychotic drug also relieves nausea from cancer chemotherapy

 
‎Wednesday, ‎July ‎13, ‎2016, ‏‎11:11:08 PMGo to full article
By Gene Emery (Reuters Health) - Adding the cheap antipsychotic drug olanzapine to conventional anti-vomiting medicine can help prevent nausea in cancer patients, according to a new test of 380 volunteers. During the first 24 hours after chemotherapy, 74 percent of patients receiving the drug along with their chemotherapy reported no nausea. That compares to 45 among those getting placebo. The benefits continued for five days as the drug therapy continued. ...
 

FDA panel supports Novartis version of Amgen arthritis drug

 
‎Wednesday, ‎July ‎13, ‎2016, ‏‎10:33:06 PMGo to full article
The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in BaselNovartis AG's cheaper version of Amgen Inc's arthritis drug Enbrel is highly similar in potency and safety to the original and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. The panel voted 20-O that there is no clinically meaningful difference between Novartis's drug, a biologic made of living cells, and Enbrel. Copies of biologics are called biosimilars, not generics, because they are more difficult to imitate with precision.
 
 

Special footwear may not improve knee arthritis

 
‎Wednesday, ‎July ‎13, ‎2016, ‏‎6:06:23 PMGo to full article
By Kathryn Doyle (Reuters Health) - Shoes with modified midsoles designed to relieve pressure on the knee joint don’t improve pain and function for people with knee osteoarthritis any more than a new pair of regular walking shoes, according to an Australian study. Knee osteoarthritis, caused by wear and tear of the knee joint, may affect up to a quarter of women and 15 percent of men over age 60, the researchers write in Annals of Internal Medicine. “It is somewhat surprising that we did not observe greater pain relief with the Gel Melbourne OA shoes compared to conventional shoes, given that our biomechanical research previously showed that the shoes can significantly reduce loads across the inner knee compartment,” said lead author Rana S. Hinman of the University of Melbourne.
 

Could gut bacteria predict and prevent rheumatoid arthritis?

 
‎Wednesday, ‎July ‎13, ‎2016, ‏‎5:43:10 PMGo to full article
Could gut bacteria predict and prevent rheumatoid arthritis?New US research has uncovered another link between gut health and physical ailments, finding that the bacteria in the gut could potentially predict an individual's risk of developing rheumatoid arthritis. Rheumatoid arthritis is an autoimmune disorder which occurs when the body mistakenly attacks itself, breaking down tissues around joints and causing painful swelling that can erode bone and deform the joints. In the first paper, published in Genome Medicine, Dr. Taneja looked a group of rheumatoid arthritis patients, their relatives and a healthy control group.
 
 

A new reason to get on your bike: cycling may help prevent type 2 diabetes finds new study

 
‎Wednesday, ‎July ‎13, ‎2016, ‏‎5:42:30 PMGo to full article
A new reason to get on your bike: cycling may help prevent type 2 diabetes finds new studyA new large-scale study published this week has found that regular cycling can lower the risk of developing type 2 diabetes. The data was then compared with the incidence of type 2 diabetes measured in the Danish National Diabetes Registry. The results showed that those who cycled regularly were less likely to develop type 2 diabetes, and the more they cycled each week, the lower the risk was.
 
 

BRIEF-Lidds: New patent approvals for treatment of prostate cancer and NanoZolid

 
‎Wednesday, ‎July ‎13, ‎2016, ‏‎10:35:57 AMGo to full article
July 13 (Reuters) - Lidds AB : * Says patent authority in Soth Africa has approved LIDDS patent for treatment of prostatecancer * Says has received Notice of Allowance regarding patent for treatment of prostate cancer inNorway * Has also received Notice of Allowance from patent offices in South Korea and Hong Kong forNanoZolid technologySource text for Eikon: Further company coverage: (Gdynia Newsroom)
 

Shares of Juno Therapeutics jump after FDA removes clinical hold on cancer drug trial

 
‎Wednesday, ‎July ‎13, ‎2016, ‏‎12:26:35 AMGo to full article
The headquarters of the U.S. Food and Drug Administration is shown in Silver Spring near WashingtonLast week, the U.S. Food and Drug Administration halted the mid-stage trial of the company's genetically engineered cancer drug after three leukemia patients died from side effects. Juno said the deaths occurred after the chemotherapy agent fludarabine was added to the trial program. The drug, JCAR015, is an experimental therapy requiring a complicated process of extracting immune system T cells from an individual patient, altering their DNA to sharpen their ability to spot and kill cancer cells, and infusing them back into the same patient.
 
 

FDA panel backs Amgen copy of AbbVie arthritis drug Humira

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎11:43:55 PMGo to full article
File photo of an Amgen sign at the company's office in South San FranciscoAmgen Inc's cheaper version of AbbVie's top-selling arthritis drug Humira is highly similar to the original and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday. The panel voted 26-0 that the drug, ABP 501, which was studied in rheumatoid arthritis and plaque psoriasis, was similar in safety and effectiveness to the original. AbbVie is trying to block Amgen's drug from reaching the market.
 
 

Many high-risk patients missed by diabetes screening

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎9:56:51 PMGo to full article
Many high-risk patients missed by diabetes screeningMore than half of people at high risk for diabetes are missed under current US screening guidelines, including many African-Americans, Hispanics and those who are not overweight, researchers said Tuesday. The government guidelines -- issued just last year -- missed 55 percent of people with prediabetes or diabetes, said the study by Northwestern Medicine. The 2015 guidelines, which were authored by the United States Preventive Service Task Force (USPSTF), recommend that people undergo screening for diabetes if they are aged 40 to 70 years old and are overweight or obese.
 
 

New study shows the importance of family history in the risk of developing prostate cancer

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎9:48:18 PMGo to full article
New study shows the importance of family history in the risk of developing prostate cancerAlthough it is already known that men with prostate cancer in the family have a higher risk of the cancer themselves, this marks the first time ever that researchers have estimated the risk of developing various types of prostate cancer for men with the disease in the family. Researchers at Umeå University and Lund University analyzed the prostate cancer risk in 51,897 men in Sweden taking part in Prostate Cancer data Base Sweden (PCBaSe) whose brothers and fathers already had prostate cancer.
 
 

Unrealistic expectations may hinder blood cancer patients' care

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎8:41:20 PMGo to full article
By Kathryn Doyle (Reuters Health) - The biggest barrier to high-quality end-of-life care for patients with blood cancers may be unrealistic expectations, a new survey found. For patients with solid-tumor cancers, standards for quality end-of-life care include not receiving chemotherapy in the last two weeks before death, and not being intubated in the final month. Doctors caring for patients with blood cancers like lymphoma or leukemia believe the same standards can apply to them, too.
 

Singer Annie Lennox urges governments to step up funding for AIDS, malaria and TB

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎7:36:22 PMGo to full article
By Astrid Zweynert LONDON (Thomson Reuters Foundation) - Ending some of the world's deadliest diseases is within reach but only if donor governments dig deeper into their pockets to fund the fight against AIDS, malaria and tuberculosis, singer and activist Annie Lennox said on Tuesday. Lennox was among activists calling on Britain to pledge 1.2 billion pounds ($1.58 billion) to the Global Fund to Fight AIDS, Tuberculosis and Malaria ahead of its summit in September to urge governments to commit more money to fighting the diseases.
 

Syrian town under siege faces famine, disease, medic groups say

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎7:35:08 PMGo to full article
By Sebastien Malo NEW YORK (Thomson Reuters Foundation) - Nearly 90 people have died from starvation and other causes during a year-old siege of the Syrian town of Madaya, where residents have been trapped without supplies, two medical organizations said on Tuesday. Government forces and allies have surrounded Madaya since July 2015 as part of Syria's six-year civil war, and the town of 40,000 people came to symbolize suffering after photos of emaciated children and reports of residents forced to eat leaves emerged this year. Sixty-five people have died from malnutrition and starvation in Madaya in the past year, according to a report by the U.S.-based Physicians for Human Rights and the Syrian American Medical Society (SAMS).
 

Redhead gene may boost skin cancer risk: study

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎6:50:01 PMGo to full article
A gene variant carried by people with red hair, pale skin and freckles may boost skin cancer risk even without exposure to the Sun's rays, researchers said Tuesday. The findings, published in the journal Nature Communications, are based on a genetic analysis of skin cancer tumours from more than 400 people. It revealed that tumours from people with a redhead variant of the MC1R gene had 42 percent more mutations -- the equivalent of 21 years of additional Sun exposure in people without it.
 

Skin cancer risk for freckly red-heads equivalent to 21 years in sun

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎5:10:38 PMGo to full article
By Kate Kelland LONDON (Reuters) - Having genes that give you red hair, pale skin and freckles increases your risk of developing skin cancer as much as an extra 21 years' exposure to the sun, researchers said on Tuesday. The researchers said even people with one copy of the crucial MC1R gene - who may be fair-skinned but not have red hair - have a higher risk. "It has been known for a while that a person with red hair has an increased likelihood of developing skin cancer, but this is the first time that the gene has been proven to be associated with skin cancers with more mutations," said David Adams, who co-led the study at Britain's Wellcome Trust Sanger Institute.
 

Sage Therapeutics surges on postpartum depression drug study

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎4:49:57 PMGo to full article
NEW YORK (AP) — A drug to treat severe postpartum depression showed positive results in a mid-stage study, sending shares developer Sage Therapeutics skyrocketing Tuesday.
 

Sage's drug for postpartum depression succeeds in mid-stage study

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎4:46:51 PMGo to full article
Sage Therapeutics Inc said its lead drug alleviated symptoms of severe postpartum depression, meeting the main goal of a small mid-stage study and sending the company's shares soaring in morning trading. About one in seven women experience postpartum depression (PPD), a severe form of "baby blues" that eventually interferes with her ability to take care of the baby and handle daily tasks, according to the American Psychological Association. Existing options include standard antidepressants and psychotherapy.
 

Research links widely used additive to food allergies

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎3:22:19 PMGo to full article
The preservative tBHQ -- used in cooking oils, chips, margarine and chicken nuggets -- could trigger allergies to eggs, milk, nuts and shellfish.The rise in food allergies could be linked to an additive by the name of tert-butylhydroquinone, or tBHQ, widely used as a food industry preservative in goods such as cooking oil, nuts, crackers, waffles and bread products, according to a researcher at Michigan State University, USA. Cheryl Rockwell, an assistant professor of pharmacology and toxicology in the College of Human Medicine, has been investigating tBHQ (tert-butylhydroquinone,) and its effects for nine years. This synthetic additive derived from benzene is often found in industrially prepared products like cooking oil or chicken nuggets.
 
 

Thumb suckers less prone to allergies: New Zealand study

 
‎Tuesday, ‎July ‎12, ‎2016, ‏‎3:48:06 AMGo to full article
Researchers have found that being exposed to microbes as a child reduces your risk of developing allergiesInfants who suck their thumbs or bite their nails appear less prone to allergies as adults, New Zealand researchers have found. Researchers then followed up by giving them allergy skin prick tests when they were aged 13 and 32. The allergy level fell to 31 percent for children who did both.
 
 

Novartis copy of Amgen arthritis drug highly similar: FDA staff

 
‎Monday, ‎July ‎11, ‎2016, ‏‎9:41:42 PMGo to full article
A Novartis logo is pictured on its headquarters building in MumbaiNovartis AG's cheaper version of Amgen Inc's blockbuster arthritis drug Enbrel is highly similar in potency and safety to the original, according to a review by Food and Drug Administration staff. The review, posted on the FDA's website on Monday, comes two days ahead of a meeting of outside advisers who will discuss the drug and recommend whether it should be approved. The FDA is not obliged to follow the recommendations of its advisory panels but typically does so.
 
 

Cancer hospital advertising triples since 2005

 
‎Monday, ‎July ‎11, ‎2016, ‏‎9:38:56 PMGo to full article
By Kathryn Doyle (Reuters Health) - Between 2005 and 2014, U.S. cancer centers upped their spending on ads targeting the general public, with 890 centers spending $173 million on ads by 2014, according to a new analysis. Spending more than tripled since 2005 and was highly concentrated among a small number of cancer centers, said study coauthor Laura B. Vater of Indiana University School of Medicine in Indianapolis. Spending on advertising does not necessarily reflect quality of care, however, the authors note.
 

Thumb-suckers, nail-biters less likely to develop allergies

 
‎Monday, ‎July ‎11, ‎2016, ‏‎9:05:23 PMGo to full article
A city worker bites his nails outside the London Stock Exchange in Paternoster Square in the City of LondonBy Kathryn Doyle (Reuters Health) - Children who suck their thumbs or bite their nails are less likely than others to have allergies later, according to a new study. According to the “hygiene hypothesis,” early life exposure to microbes may decrease the risk of developing allergies, which may explain why kids with oral habits have fewer allergies as adults, although this idea is still controversial, the authors write. In this observational study it was not possible to prove that thumb sucking or nail biting causes a reduction in allergies, said senior author Dr. Robert J. Hancox of the Dunedin School of Medicine at the University of Otago in Dunedin, New Zealand.
 
 

Swim champion Le Clos reveals both parents have cancer

 
‎Monday, ‎July ‎11, ‎2016, ‏‎8:10:33 PMGo to full article
Le Clos of South Africa swims in men's 100m butterfly heat at Aquatics World Championships in Kazan(Reuters) - South Africa's big Olympic swimming hope Chad Le Clos has revealed that both his parents are battling cancer as he prepares for next month's Rio Games. The 200 meters butterfly champion, whose father Bert became a media sensation at the London 2012 Games for his exuberant reaction to his son's gold, said he hoped they would be accompanying him to Brazil. "My mum Geraldine has breast cancer which has returned since her remission in 2010," Le Clos, who beat American Michael Phelps to gold four years ago, said in a statement.
 
 

Huge study of diabetes risk shows many common genes at play

 
‎Monday, ‎July ‎11, ‎2016, ‏‎5:25:42 PMGo to full article
A person receives a test for diabetes during Care Harbor LA free medical clinic in Los AngelesBy Julie Steenhuysen CHICAGO (Reuters) - A study examining the genes of more than 120,000 people from Europe, Asia, Africa and the Americas has offered the clearest picture yet of the genes that drive type 2 diabetes. The study, published on Monday in the journal Nature, puts to rest a decades-long debate over the genetics that influence the risk of diabetes, which affects one in 10 people over the course of their lifetime. "There was a whole furious debate that arose about this," said Dr. Francis Collins, director of the National Institutes of Health, one of more than 300 scientists collaborating on the work.
 
 

 

Weathering the Coming Storm


 

 

 

Price R399.00

 

 


 

Description

Dr. Chuck Missler, an internationally known business executive, outlines our current economic predicament and defensive steps you can take to lessen the impact of the impending economic crisis. As a Bible teacher for over 30 years with a ministry reaching over 40 countries, Chuck shares some key strategies to prepare yourself spiritually and practically.

Is the World facing another major economic upheaval?

What is the best strategy to protect your family in times of economic uncertainty?

The Church has enjoyed a relatively peaceful existence in the West for a few centuries but the with the coming persecution, how do we go about organizing home study and home-church?

Soul Survival – Keeping your “lamp full” during the hard times ahead.

Join Dr. Chuck Missler and Ron Matsen in the Executive Brie fing Room of
The River Lodge, New Zealand, in an intensive summary outlining what lies
ahead and how we can prepare for the coming storm.

Runtime: Approx. 5 hours

© 2012 Koinonia House Inc.

Available in the following formats:

 

DVD:

•3 Disks
•5 M4A Files
•1 PDF Notes File
•Color, 16:9, Dolby Digital 2.0 stereo, Region encoding (This DVD will be viewable in other countries WITH the proper DVD player and television set.)


 
 

Expectations

 of the

 Antichrist

 

 

Dr. Chuck Missler and Ron Matsen

 

Price R 499.00

 

There are many diverse anticipations concerning the Coming World Leader, commonly referred to as “The Antichrist.” This study will explore the Biblical descriptions with the specific expectations of the globalists, Islam, the Vatican, Freemasonry, and others.
• Will he be a Nephilim?
• Why is the Vatican openly preparing to receive an “alien” visitor?
• Will he be a resurrection of Nimrod? Is his DNA a factor?
• What are the expectations of transhumanist technologists in this regard?
Clearly, the Bible has much more to illuminate this issue far beyond the popular conceptions; and yet the composite perspective will astonish most. Furthermore, is there a climactic cosmic deception being prepared that, if it were possible, “it would deceive the very elect”? Jesus commanded us, “Be not deceived.” But, how?
How close are these events to our current horizon?
Join Dr. Chuck Missler and Ron Matsen in an intensive summary of some of the Strategic Trends that will impact all of us.
Available in the following formats:

DVD:
•3 Discs
•6 M4A Files
•1 PDF Notes File
•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region  encoding ( This DVD will be viewable in other countries WITH the proper DVD player and television set.)


 

 

 

Feed image

 

 

 

 

 
 

 

Genetically Modified Food & People.

 

 

 

 Angels, Volume III:

The Denizens of the Metacosm

 

DVD

 

 

Price R 179.00

 

Angels, Volume III: The Denizens of the Metacosm

 

DVD

by Dr. Chuck Missler

 

Description

Volumes 1 & 2 of this series explored the finite limits and boundaries of our physical reality. After probing the limits of both the Macrocosm and the Microcosm, we discovered that our reality is but a shadow of larger reality, the Metacosm, a domain of extra-dimensional transfers and other paradoxical phenomena.

 

Volume 3 explores the contradictory behavior of UFOs and other demonic deceptions characteristic of the End Times. Explore these topics in more detail in either this two-hour briefing, Angels Vol 3: The Denizens of the Metacosm or our six-hour extensive study, Expectations of the Antichrist.

 

 

• Are they real?

• Why do UFOs enjoy a military classification higher than our most sensitive weapons systems?

• Why are the events which occurred in Roswell New Mexico still classified after 66 years?

• Why is the Vatican openly preparing to receive an Alien Visitor?

• How should a Christian deal with the occurrences of Alien abductions?

• Jesus admonished us to “Be not deceived.” How?

• How do we prepare for the deception which, “if it were possible, would deceive the very elect”?

 

Join Dr. Chuck Missler in the Executive Briefing Room of the River Lodge, New Zealand, exploring the misinformation, (and deliberate disinformation) about the various “denizens of the Metacosm” and other insights of the invisible war unfolding on our near horizon.

 

This briefing pack contains 2 hours of teaching

 

Available in the following formats

 

DVD:

•1 Disc

•2 M4A Files

•Color, Fullscreen 16:9, Dolby Digital 2.0 stereo, Region. This DVD will be viewable in other countries WITH the proper DVD player and television set.)

 

DVD

PRICE  R 159.00

DVD

PRICE R 159.00

 

DVD

Price  R 159.00

 

DVD

Price R 159.00

 

 

 

 

 

 

 

 

 

 

 

 


Global Events Disaster Site


Extreme Weather, Epidemic, Terror Attack, Biological Hazard,

Volcano Eruption, Earthquake, Incidents at Sea

 

 

"In seasons of severe trial, the Christian has nothing on earth that he can trust to, and is therefore compelled to cast himself on God alone. When no human deliverance can avail, he must simply and entirely trust himself to the providence and care of God. Happy storm that wrecks a man on such a rock as this! O blessed hurricane that drives the soul to God--and God alone!"
- Spurgeon

 

 

 

 

+27 11 969 0086


frosty@khouseafrica.com   

 

 

 

 

 

 

 

 

 

 

 

 

 


Bible

DVD

+

MP3 on CD-ROM
Featured Commentaries

Learn the Bible

 in 24 hours



Old Testament


Genesis

Exodus

Leviticus

Numbers

Deuteronomy

Joshua and The Twelve Tribes

Judges

Ruth and Esther

I and II Samuel

I and II Kings

I and II Chronicles

Ezra & Nehemiah

Job

Psalms

Proverbs

Ecclesiastes

Song of Songs

Isaiah

Jeremiah

/Lamentations

Ezekiel

Daniel

Hosea

Joel and Amos

Jonah, Nahum & Obadiah

Micah

Zechariah

The Minor

Prophets

 



New Testament


Matthew

Mark

Luke

John

Acts

Romans

I & II Corinthians

Galatians

Ephesians

Philippians

Colossians and Philemon

I and II

Thessalonians

Timothy/

Titus/Philemon

Hebrews

James

I and II Peter

I, II, and III John

Jude

Revelation